Myriad Genetics
  • Internationalen
    • Francefr
    • Italiait
    • Españaes
    • UK/Irelandgb
search
search
  • Home
  • Healthcare Professionals
    • Hereditary Cancer Testing
      • Hereditary Breast and Ovarian Cancer (HBOC) Syndrome
      • Hereditary Colon and Gynecologic Cancers – Lynch Syndrome (HNPCC), MAP
      • Hereditary Colon and Gynecologic Cancers – Polyposis Syndromes (FAP, AFAP MAP)
      • Hereditary Pancreatic Cancer
      • Hereditary Melanoma
    • Prognostic Medicine
    • Personalized Medicine
    • Companion Diagnostic
    • References
    • Professional Practice Guidelines
    • Patient Education
  • Patients
    • Hereditary Cancer
      • Genetic Testing
      • Hereditary Cancer Quiz
    • Prognostic Testing
      • Prostate Cancer
      • Breast Cancer
      • Companion Diagnostic Testing
    • Resources for Patients
  • Products
    • myRisk®
    • BRACAnalysis ®
    • Colaris®
    • Colaris AP®
    • EndoPredict®
    • Prolaris®
    • Tumor BRACAnalysis CDxTM
  • Future Innovation
    • Myriad RBM
    • Product Pipeline
    • Partnering and Licensing
    • Companion Diagnostic
  • About Myriad
    • History
    • Myriad International
    • Munich Laboratory
      • DAkkS certificate
    • Myriad International Management Team
    • Locations & Contacts
    • Contact Us

Hereditary Cancer Testing

  • Hereditary Breast and Ovarian Cancer (HBOC) Syndrome
    • Etiology and Clinical Features of Hereditary Breast and Ovarian Cancer (HBOC)
    • HBOC Cancer Risks
    • Identifying HBOC Patients
    • Ovarian Cancer Patients
    • Benefits of BRACAnalysis® Testing
    • Medical Management with HBOC
    • Sample BRACAnalysis® Test Results
    • HBOC Clinical Summaries
    • HBOC FAQs
    • Prevalence Tables
    • Physician Resources
    • Patient Education
  • Hereditary Colon and Gynecologic Cancers – Lynch Syndrome (HNPCC), MAP
    • Etiology and Clinical Features of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) and MYH-associated polyposis (MAP)
    • Lynch Syndrome and MAP Cancer Risks
    • Identifying Patients at Risk for Lynch Syndrome and MAP
    • Benefit of COLARIS® Testing
    • Managing Patients with Lynch Syndrome or MYH-associated Polyposis (MAP)
    • Lynch Syndrome Clinical Summaries
    • The Myriad Advantage
    • COLARIS® FAQs
    • Prevalence Tables
    • Physician Resources
  • Hereditary Colon and Gynecologic Cancers – Polyposis Syndromes (FAP, AFAP MAP)
    • Etiology and Clinical Features of Adenomatous Polyposis Syndrome
    • Adenomatous Polyposis Syndromes Cancer Risks
    • Identifying Patients at Risk for Adenomatous Polyposis Syndromes
    • Benefits of COLARIS AP® Testing
    • Managing Patients with Adenomatous Polyposis Syndromes
    • COLARIS AP® FAQ
  • Hereditary Pancreatic Cancer
    • Etiology and Clinical Features of Hereditary Pancreatic Cancer
    • Cancer Risks Associated with a BRCA2 or PALB2 Mutation
    • Identifying Patients at Risk for Hereditary Pancreatic Cancer
    • Benefits of PANEXIATM Testing
    • Managing Patients with Hereditary Pancreatic Cancer
  • Hereditary Melanoma
    • Etiology and Clinical Features of Hereditary Melanoma Syndrome
    • Melanoma and Pancreatic Cancer Risks
    • Identifying Patients at Risk for Hereditary Melanoma
    • Benefits of MELARIS® Testing
    • Managing Patients with Hereditary Melanoma Syndrome

Hereditary Melanoma

Home / Healthcare Professionals / Hereditary Cancer Testing / Hereditary Melanoma

To discover more about Hereditary Melanoma click on a topic of the menu on the left


  • Home
  • Healthcare Professionals
    • Hereditary Cancer Testing
      • Hereditary Breast and Ovarian Cancer (HBOC) Syndrome
      • Hereditary Colon and Gynecologic Cancers – Lynch Syndrome (HNPCC), MAP
      • Hereditary Colon and Gynecologic Cancers – Polyposis Syndromes (FAP, AFAP MAP)
      • Hereditary Pancreatic Cancer
      • Hereditary Melanoma
    • Prognostic Medicine
    • Personalized Medicine
    • Companion Diagnostic
    • References
    • Professional Practice Guidelines
    • Patient Education
  • Patients
    • Hereditary Cancer
      • Genetic Testing
      • Hereditary Cancer Quiz
    • Prognostic Testing
      • Prostate Cancer
      • Breast Cancer
      • Companion Diagnostic Testing
    • Resources for Patients
  • Products
    • myRisk®
    • BRACAnalysis ®
    • Colaris®
    • Colaris AP®
    • EndoPredict®
    • Prolaris®
    • Tumor BRACAnalysis CDxTM
  • Future Innovation
    • Myriad RBM
    • Product Pipeline
    • Partnering and Licensing
    • Companion Diagnostic
  • About Myriad
    • History
    • Myriad International
    • Munich Laboratory
      • DAkkS certificate
    • Myriad International Management Team
    • Locations & Contacts
    • Contact Us

  • Data Protection and Privacy Statement
  • Privacy Policy
  • Terms of Use

Copyright © 2018 Myriad Genetics all rights reserved.

Close

This website intends to use cookies. Cookies provide information on the way that you use the website in order to improve your experience and to make statistics. By continuing to browse the site you are agreeing to accept our use of “cookies”. You will find more information about “cookies” on our privacy policy page. Privacy Policy Privacy Policy